Ovarian and cervical cancer awareness: Development of two validated measurement tools

Journal of Family Planning and Reproductive Health Care

Volumn 38, Issue 3, 2012, Pages 167-174

  Simon, Alice E ^a   Wardle, Jane ^a   Grimmett, Chloe ^a   Power, Emily ^a   Corker, Elizabeth ^a   Menon, Usha ^a   Matheson, Lauren ^a   Waller, Jo ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CERVICAL CANCER AWARENESS MEASURE; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; CONTENT VALIDITY; CONTROLLED STUDY; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MEDICAL EXPERT; OVARIAN CANCER AWARENESS MEASURE; OVARY CANCER; PSYCHOMETRY; TEST RETEST RELIABILITY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; AWARENESS; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; PAMPHLETS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84864412222     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1136/jfprhc-2011-100118     Document Type: Article

References (17)

1. Richards MA. The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009;101(Suppl.2):S1-S4.
2. Stubbings S, Robb K, Waller J, et al. Development of a measurement tool to assess public awareness of cancer. Br J Cancer 2009;101(Suppl.2):S13-S17.
3. Cancer Research UK. CancerStats Key Facts Ovarian Cancer. Cancer Research UK, 2009. http://info.cancerresearchuk.org/cancerstats/types/ovary/survival/ [accessed 7 April 2011].
4. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-991.
5. Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer 2009;101(Suppl.2):S102-S109.
6. Engel J, Eckel R, Schubert-Fritschle G, et al. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer 2002;38:2435-2445.
7. Horn LC, Fischer U, Raptis G, et al. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 2007;107:310-315.
8. Ott JJ, Ullrich A, Miller AB. The importance of early symptom recognition in the context of early detection and cancer survival. Eur J Cancer 2009;45:2743-2748.
9. Department of Health. Cervical Cancer - Key Messages. NHS Choices. 2010. http://www.nhs.uk/Conditions/Cancer-of-the-cervix/Pages/Keymessages.aspx [accessed 7 April 2011].
10. Department of Health. Key Messages for Ovarian Cancer for Health Professionals. London, UK: Department of Health, 2009.
11. Gynecologic Cancer Foundation. Ovarian Cancer Symptom Consensus Statement, 2007. http://www.wcn.org/articles/types-of-cancer/ovarian/symptoms/ concensus-statement.html [accessed 7 April 2011].
12. Viswanath K, Breen N, Meissner H, et al. Cancer knowledge and disparities in the information age. J Health Commun 2006;11(Suppl.1):1-17.
13. Devllis R. Scale Development: Theory and Applications (2nd edn). Thousand Oaks, CA: Sage Publications, 2003.
14. Kline P. The Handbook of Psychological Testing (2nd edn). London, UK: Routledge, 2000.
15. Bland JM, Altman DG. Cronbach's alpha. BMJ 1997;314:572.
16. National Institute for Health and Clinical Excellence (NICE). Ovarian Cancer: Full Guideline for Consultation. London, UK: NICE, 2010.
17. Hamilton W, Peters TJ, Bankhead C, et al. Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ 2009;339:b2998.